Wilson Roa
Overview
Explore the profile of Wilson Roa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1686
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Pastena F, Pond G, Tsakiridis E, Gouveia A, Ahmadi E, Biziotis O, et al.
Radiat Oncol
. 2024 Nov;
19(1):155.
PMID: 39511611
Introduction: Growth differentiation factor 15 (GDF15) is a cytokine of the TGFβ family. Here, we analyzed GDF15 levels in patients with locally advanced non-small cell lung cancer (LA-NSCLC) who participated...
2.
Wang M, Roa W, Wachowicz K, Yahya A, Murtha A, Amanie J, et al.
Anticancer Res
. 2022 Apr;
42(5):2665-2673.
PMID: 35489774
Background: The purpose of this study was to evaluate the association of specific threshold values for changes in metabolic metrics measured from 1H magnetic resonance spectroscopic imaging (MRSI) to survival...
3.
Song A, Ding K, Alnahhas I, Laperriere N, Perry J, Mason W, et al.
Neurooncol Adv
. 2022 Jan;
4(1):vdac011.
PMID: 35098127
[This corrects the article DOI: 10.1093/noajnl/vdab153.].
4.
Song A, Ding K, Alnahhas I, Laperriere N, Perry J, Mason W, et al.
Neurooncol Adv
. 2021 Nov;
3(1):vdab153.
PMID: 34765975
Background: Lymphopenia may lead to worse outcomes for glioblastoma patients. This study is a secondary analysis of the CCTG CE.6 trial evaluating the impact of chemotherapy and radiation on lymphopenia,...
5.
Tsakiridis T, Pond G, Wright J, Ellis P, Ahmed N, Abdulkarim B, et al.
JAMA Oncol
. 2021 Jul;
7(9):1333-1341.
PMID: 34323924
Importance: Unresected locally advanced non-small cell lung cancer (LA-NSCLC) shows poor survival outcomes even after aggressive concurrent chemoradiotherapy. Whether metformin, a diabetes agent that inhibits the mitochondria oxidative phosphorylation chain,...
6.
Menon A, Abraham A, Mahfouz M, Thachuthara J, Usmani N, Warkentin H, et al.
Am J Clin Oncol
. 2021 Jul;
44(9):487-494.
PMID: 34269694
Aim: Capecitabine (Cape) is routinely used for the neoadjuvant chemoradiation treatment (NACRT) of locally advanced rectal cancers (LARCs). Previous reports have suggested that the concomitant use of proton pump inhibitors...
7.
Abraham A, Roa W
J Thorac Dis
. 2021 Jun;
13(5):3235-3245.
PMID: 34164216
Small cell lung cancers (SCLC) are a group of cancers that are clinically and pathologically different from other lung cancers. They are associated with high recurrence rates and mortality, and...
8.
Jamaluddin M, Abraham A, Menon G, Nakatsui T, Roa W
Breast J
. 2021 Mar;
27(6):543-546.
PMID: 33763948
Radiation recall dermatitis is an inflammatory reaction of the skin, which occurs at previously irradiated areas, usually following a subsequent exposure to an aggravating factor. Recall dermatitis can occur weeks...
9.
Climans S, Brandes A, Cairncross J, Ding K, Fay M, Laperriere N, et al.
J Neurooncol
. 2020 Jul;
149(1):65-71.
PMID: 32632894
Introduction: Tumor-related epilepsy may respond to chemotherapy. In a previously-published multi-centre randomized clinical trial of 562 elderly glioblastoma patients, temozolomide plus short-course radiotherapy conferred a survival benefit over radiotherapy alone....
10.
Watanabe S, Faily V, Mawani A, Huot A, Tarumi Y, Potapov A, et al.
Oncologist
. 2020 May;
25(8):722-728.
PMID: 32445194
Introduction: Early integration of palliative care (PC) with oncological care is associated with improved outcomes in patients with advanced cancer. Limited information exists on the frequency, timing, and predictors of...